跳至主要内容
临床试验/NCT01538992
NCT01538992撤回3 期

Phase 3 Study of Renal Denervation That Improves Symptoms of Heart Failure and Enhances Life Quality in Advanced Heart Failure

Bursa Postgraduate Hospital1 个研究点 分布在 1 个国家开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
试验地点
1
主要终点
Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events

研究概览

简要总结

Sympathetic system has important role occurrence of symptoms in heart failure. Renal denervation that is ablated some of sympathetic nerves is affected pathology of heart failure. This interventional therapy improves symptoms and life quality.

详细描述

Primary Outcome Measures:

• Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events

Secondary Outcome Measures:

• Ventricular function,NYHA functional Class, 6 min walking test, biochemical test and Renal function as measured by Glomerular Filtration Rate (GFR)

Eligibility Patients population: Volunteers, NYHA Class III-IV heart failure patients. Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Heart Failure patients NYHA Class III or IV
  • Left Ventricular Ejection Function < 35%
  • GFR > 45 mL/min/1.73m2
  • Optimal stable medical therapy

排除标准

  • Do not eligible renal artery anatomy for treatment as determined by Angiography, and
  • History of prior renal artery intervention
  • Single functioning kidney.
  • Myocardial Infarction, unstable angina pectoris or cerebrovascular Accident within 3 months
  • Systolic BP < 110mmHG Hospitalisation because of heart failure in last 3 weeks.

结局指标

主要结局

Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events

时间窗: 6 months

次要结局

  • • Ventricular function as measured by Echocardiography • NYHA functional Class, 6 min walking test, biochemical test. • Renal function as measured by Glomerular Filtration Rate (GFR)(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hasan ARI

Medical Doctor, Cardiology Chief Intern

Bursa Postgraduate Hospital

研究点 (1)

Loading locations...

相似试验